clofarabine has been researched along with Pancreatitis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borowitz, M; Burke, MJ; Carroll, AJ; Carroll, WL; Chen, S; Devidas, M; Gore, L; Heerema, NA; Hilden, JM; Hunger, SP; Larsen, EC; Loh, ML; Raetz, EA; Salzer, WL; Winick, NJ; Wood, B | 1 |
1 trial(s) available for clofarabine and Pancreatitis
Article | Year |
---|---|
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Child; Child, Preschool; Clofarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Pancreatitis; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Severity of Illness Index; Young Adult | 2018 |